Abstract
The aim of this study was to determine whether toll-like receptor (TLR) polymorphisms confers susceptibility to vasculitis. A literature search was conducted using the PubMed and Embase. A meta-analysis on the associations between the TLR4 Asp299Gly polymorphisms and vasculitis was carried out using allele contrast, dominant, and codominant models and a systematic review of other TLR polymorphisms. Fourteen studies involving 2,064 patients and 2,481 controls were included in this systematic review, which comprised nine on Behcet’s disease (BD), three on giant cell arteritis (GCA), and one on Henoch–Schenlein purpura (HSP). Meta-analysis of six studies showed a significant association between the Gly/Gly+Gly/Asp genotype of the TLR4 Asp299Gly polymorphism and vasculitis and GCA (Odds ratio [OR] = 1.368, 95 % confidence interval [CI] = 1.300–1.815, p = 0.030; OR = 1.523, 95 % CI = 1.099–2.112, p = 0.012). Under a random effects model, the adjusted ORs calculated using the trim and fill technique revealed an association between the Gly/Gly+Gly/Asp genotype of the TLR4 Asp299Gly polymorphism and vasculitis (OR = 1.544, 95 % CI = 1.091–2.185, p < 0.05). Stratification by vasculitis type using the codominant model showed the trend for the association with GCA (OR = 1.569, 95 % CI = 0.970–2.538, p = 0.066). There were three studies on the TLR2 Arg753Gln polymorphism and two on the TLR4 Thr399Ile polymorphism; no association with vasculitis was evident. Among the TLR2, TLR7, and TLR9 polymorphisms included in this review, one Asian study revealed a significant association between the TLR7 rs5743733 and rs3853839 with BD (p = 0.002, 0.036) and one Asian study showed an association of TLR9 rs352140 with BD (p = 0.009). This meta-analysis demonstrates that the TLR4 Asp299Gly polymorphism may confer susceptibility to GCA. The review of published data suggests that other TLR polymorphisms such as TLR7 and TLR9 may play a role in vasculitis.
Similar content being viewed by others
References
Bloch DA, Michel BA, Hunder GG, Mcshane DJ, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Fries JF, Leavitt RY, Lie JT, Lightfoot RW, Masi AT, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis—patients and methods. Arthritis Rheum 33:1068–1073
Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335–376
Moon SJ, Park MK, Oh HJ, Lee SY, Kwok SK, Cho ML, Ju JH, Park KS, Kim HY, Park SH (2010) Engagement of toll-like receptor 3 induces vascular endothelial growth factor and interleukin-8 in human rheumatoid synovial fibroblasts. Korean J Intern Med 25:429–435
Drexler SK, Foxwell BM (2010) The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol 42:506–518
Rahman AH, Eisenberg RA (2006) The role of toll-like receptors in systemic lupus erythematosus. Springer Semin Immunopathol 28:131–143
Alvarez-Rodriguez L, Munoz Cacho P, Lopez-Hoyos M, Beares I, Mata C, Calvo-Alen J, Villa I, Martinez-Taboada VM (2011) Toll-like receptor 4 gene polymorphism and giant cell arteritis susceptibility: a cumulative meta-analysis. Autoimmun Rev 10:790–792
Sada T, Ota M, Katsuyama Y, Meguro A, Nomura E, Uemoto R, Nishide T, Okada E, Ohno S, Inoko H, Mizuki N (2011) Association analysis of Toll-like receptor 7 gene polymorphisms and Behcet’s disease in Japanese patients. Hum Immunol 72:269–272
Torres O, Palomino-Morales R, Miranda-Filloy JA, Vazquez-Rodriguez TR, Martin J, Gonzalez-Gay MA (2010) Lack of association between toll-like receptor 4 gene polymorphism and Henoch-Schonlein purpura. Clin Exp Rheumatol 28:110
Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, Cimino L, Bajocchi GL, Catanoso MG, Pattacini L, Ghinoi A, Restuccia G, Salvarani C (2009) Toll-like receptor 4 (TLR4) gene polymorphisms in giant cell arteritis. Clin Exp Rheumatol 27:S40–S44
Ben Dhifallah I, Lachheb J, Houman H, Hamzaoui K (2009) Toll-like-receptor gene polymorphisms in a Tunisian population with Behcet’s disease. Clin Exp Rheumatol 27:S58–S62
Boiardi L, Atzeni F, Casali B, Farnetti E, Nicoli D, Pipitone N, Catanoso MG, Olivieri I, Cantini F, Salvi F, La Corte R, Triolo G, Filippini D, Paolazzi G, Salvarani C (2009) Toll-like receptor 4 (TLR4) gene polymorphisms in Italian patients with Behcet’s disease. Clin Exp Rheumatol 27:S43–S47
Cosan F, Oku B, Cakiris A, Duymaz-Tozkir J, Mercanoglu F, Saruhan-Direskeneli G, Ustek D, Gul A (2009) No association of the TLR2 gene Arg753Gln polymorphism with rheumatic heart disease and Behcet’s disease. Clin Rheumatol 28:1385–1388
Soylu A, Kizildag S, Kavukcu S, Cingoz S, Turkmen M, Demir BK, Sakizli M (2010) TLR-2 Arg753Gln, TLR-4 Asp299Gly, and TLR-4 Thr399Ile polymorphisms in Henoch Schonlein purpura with and without renal involvement. Rheumatol Int 30:667–670
Palomino-Morales R, Torres O, Vazquez-Rodriguez TR, Morado IC, Castaneda S, Callejas-Rubio JL, Miranda-Filloy JA, Fernandez-Gutierrez B, Martin J, Gonzalez-Gay MA (2009) Association between toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis. J Rheumatol 36:1501–1506
Horie Y, Meguro A, Ota M, Kitaichi N, Katsuyama Y, Takemoto Y, Namba K, Yoshida K, Song YW, Park KS, Lee EB, Inoko H, Mizuki N, Ohno S (2009) Association of TLR4 polymorphisms with Behcet’s disease in a Korean population. Rheumatology (Oxford) 48:638–642
Tomiyama R, Meguro A, Ota M, Katsuyama Y, Nishide T, Uemoto R, Iijima Y, Ohno S, Inoko H, Mizuki N (2009) Investigation of the association between Toll-like receptor 2 gene polymorphisms and Behcet’s disease in Japanese patients. Hum Immunol 70:41–44
Meguro A, Ota M, Katsuyama Y, Oka A, Ohno S, Inoko H, Mizuki N (2008) Association of the toll-like receptor 4 gene polymorphisms with Behcet’s disease. Ann Rheum Dis 67:725–727
Ito A, Ota M, Katsuyama Y, Inoko H, Ohno S, Mizuki N (2007) Lack of association of Toll-like receptor 9 gene polymorphism with Behcet’s disease in Japanese patients. Tissue Antigens 70:423–426
Bacanli A, Sallakci N, Yavuzer U, Alpsoy E, Yegin O (2006) Toll-like receptor 2 Arg753Gln gene polymorphism in Turkish patients with Behcet’s disease. Clin Exp Dermatol 31:699–701
Alvarez-Rodriguez L, Lopez-Hoyos M, Beares I, Munoz Cacho P, Mata C, Calvo-Alen J, Corrales A, Tripathi G, Blanco R, Garcia-Unzueta M, Villa I, Martinez-Taboada VM (2011) Lack of association between Toll-like receptor 4 gene polymorphisms and giant cell arteritis. Rheumatology (Oxford) 50:1562–1568
Nath SK, Harley JB, Lee YH (2005) Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. Hum Genet 118:225–234
Lee YH, Harley JB, Nath SK (2006) Meta-analysis of TNF-alpha promoter −308 A/G polymorphism and SLE susceptibility. Eur J Hum Genet 14:364–371
Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2006) Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis. Rheumatol Int 27:157–161
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455–463
Davey Smith G, Egger M (1997) Meta-analyses of randomised controlled trials. Lancet 350:1182
Egger M, Smith GD, Phillips AN (1997) Meta-analysis: principles and procedures. BMJ 315:1533–1537
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558
Durrani O, Banahan K, Sheedy FJ, McBride L, Ben-Chetrit E, Greiner K, Vaughan RW, Kondeatis E, Hamburger J, Fortune F, Stanford MR, Murray PI, O’Neill LA, Wallace GR (2011) TIRAP Ser180Leu polymorphism is associated with Behcet’s disease. Rheumatology (Oxford) 50:1760–1765
Alvarez Rodriguez L, Lopez-Hoyos M, Mata C, Fontalba A, Calvo Alen J, Marin MJ, Fernandez-Luna JL, Aguero Balbin J, Aranzamendi Zaldunbide M, Blanco R, Martinez-Taboada VM (2011) Expression and function of toll-like receptors in peripheral blood mononuclear cells of patients with polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 70:1677–1683
Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Gonzalez-Louzao C, Rodriguez-Ledo P (2001) Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 30:249–256
Barnes CG (1999) Behcet’s syndrome–classification criteria. Ann Med Interne (Paris) 150:477–482
Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, Edworthy SM, Fauci AS, Leavitt RY, Lie JT et al (1990) The American College of Rheumatology 1990 criteria for the classification of Henoch–Schonlein purpura. Arthritis Rheum 33:1114–1121
Weyand CM, Ma-Krupa W, Pryshchep O, Groschel S, Bernardino R, Goronzy JJ (2005) Vascular dendritic cells in giant cell arteritis. Ann N Y Acad Sci 1062:195–208
Ma-Krupa W, Kwan M, Goronzy JJ, Weyand CM (2005) Toll-like receptors in giant cell arteritis. Clin Immunol 115:38–46
Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187–191
Palomino-Morales RJ, Vazquez-Rodriguez TR, Torres O, Morado IC, Castaneda S, Miranda-Filloy JA, Callejas-Rubio JL, Fernandez-Gutierrez B, Gonzalez-Gay MA, Martin J (2010) Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis. Arthritis Res Ther 12:R51
Garcia-Bermudez M, Lopez-Mejias R, Gonzalez-Juanatey C, Castaneda S, Miranda-Filloy JA, Blanco R, Fernandez-Gutierrez B, Balsa A, Gonzalez-Alvaro I, Gomez-Vaquero C, Llorca J, Martin J, Gonzalez-Gay MA (2012) Lack of association between TLR4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis. DNA Cell Biol 31:1214–1220
Broen JC, Bossini-Castillo L, van Bon L, Vonk MC, Knaapen H, Beretta L, Rueda B, Hesselstrand R, Herrick A, Worthington J, Hunzelman N, Denton CP, Fonseca C, Riemekasten G, Kiener HP, Scorza R, Simeon CP, Ortego-Centeno N, Gonzalez-Gay MA, Airo P, Coenen MJ, Martin J, Radstake TR, Spanish Systemic Sclerosis Group (2012) A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators. Arthritis Rheum 64:264–271
Sanchez E, Callejas-Rubio JL, Sabio JM, Gonzalez-Gay MA, Jimenez-Alonso J, Mico L, de Ramon E, Camps M, Suarez A, Gutierrez C, Garcia-Portales R, Tolosa C, Ortego-Centeno N, Sanchez-Roman J, Garcia-Hernandez FJ, Gonzalez-Escribano MF, Martin J (2009) Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus. Clin Exp Rheumatol 27:267–271
Acknowledgments
This study was supported by a Korea University Grant.
Conflict of interest
The authors have no potential conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Song, G.G., Choi, S.J., Ji, J.D. et al. Toll-like receptor polymorphisms and vasculitis susceptibility: meta-analysis and systematic review. Mol Biol Rep 40, 1315–1323 (2013). https://doi.org/10.1007/s11033-012-2175-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-012-2175-x